GAMCO Investors’s iShares Biotechnology ETF IBB Stock Holding History

GAMCO Investors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$656K	–	887
2022 Q4	$656K	Hold	5,000	–	–	0.01%	660
2022 Q3	$585K	Buy	5,000 +3,000	+150%	+$373K	0.01%	660
2022 Q2	$235K	Buy	+2,000	New	+$237K	﹤0.01%	816
2020 Q4	–	Sell	-12,500	Closed	-$1.69M	–	895
2020 Q3	$1.69M	Buy	+12,500	New	+$1.7M	0.02%	492

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GAMCO Investors's IBB Position: Q1 2023 in Review

GAMCO Investors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 5,000 shares — an estimated $656K sold.

GAMCO Investors first reported a position in IBB in Q3 2020 and held it in 4 quarters. The position peaked at $1.69M in Q3 2020. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

GAMCO Investors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
GAMCO Investors sold 5,000 iShares Biotechnology ETF shares in Q1 2023, an estimated $656K.
GAMCO Investors first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 4 quarters.
GAMCO Investors's iShares Biotechnology ETF position peaked at $1.69M in Q3 2020.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.